TMS as a Performance Protocol, Not a Last Resort
TMS earned its reputation in treatment-resistant depression, and that framing quietly capped how the field uses it. Read as a plasticity tool with a target, a dose and a schedule, it becomes something more interesting.
By Elena Marsh · Editor
The last-resort framing is an insurance artifact
Transcranial magnetic stimulation entered mainstream practice through the narrowest possible door: patients who had already failed two or more antidepressant trials. That criterion is a reimbursement rule, not a statement about mechanism. It tells you who an insurer will pay for, not who the tool helps.
Underneath, TMS is a targeted plasticity intervention. Focused magnetic pulses drive activity in a cortical region — most often the left dorsolateral prefrontal cortex — and repeated sessions shift the excitability of the network attached to it. That is a dose-response system, and dose-response systems reward precision.
What actually varies between clinics
Three variables move outcomes more than anything printed on a brochure.
Targeting. Scalp measurement is the cheap default. Neuronavigated targeting, ideally informed by imaging, places the coil against the same functional region every visit instead of approximately near it. Ask which one you are getting.
Dose and protocol. Standard high-frequency rTMS runs daily for four to six weeks. Intermittent theta-burst compresses each session to a few minutes. Accelerated protocols deliver many sessions per day across a single week. These are not interchangeable; they suit different schedules, budgets and response profiles.
Measurement cadence. A clinic that scores you at intake and discharge is guessing in between. A clinic that scores you weekly can adjust intensity, change target, or stop early.
Sequencing it with everything else
A TMS course is five to six weeks of repeatedly opening the same window. What you do around it is not a lifestyle footnote.
Sleep debt suppresses consolidation, so a protocol run through a brutal travel quarter will underperform the same protocol run in a protected month. Alcohol raises seizure-threshold concerns and blunts sleep quality; most serious programs ask you to cut it entirely. Benzodiazepines damp cortical excitability and can measurably reduce response — a conversation to have with your prescriber before session one, not week four.
On the other side, deliberate cognitive engagement immediately after a session appears to matter. Several programs now pair stimulation with a task that recruits the same network, on the logic that a stimulated circuit should be given something to encode.
Realistic expectations
Response is not universal, and honest clinics say so. Meaningful improvement in a majority of treatment-resistant patients, remission in a substantial minority, and a durability question that depends heavily on maintenance. For people using TMS outside that population — for cognitive and emotional optimization rather than rescue — the evidence base is thinner and the honest framing is experimental, elective, and closely monitored.
That is not a reason to avoid it. It is a reason to insist on measurement.
The questions that separate good from mediocre
How is my target located? What is your protocol and why that one for me? How often will you re-score me, and what change would make you alter course? What is the per-session rate if I stop early? What does maintenance look like at month six?
Providers running a serious program answer these in specifics. Everyone else answers in adjectives.
Keep sharpening the protocol.
One protocol breakdown every other Tuesday.